ATLAS / Macro Radar / Reporting / VOR

Vor Biopharma Inc. (VOR) reporting calendar

Vor Biopharma Inc. files periodic reports with the SEC as VOR on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
18 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001193125-26-220689
10-K31 Dec 202530 Mar 202689 days0001193125-26-130451
10-Q30 Sep 202513 Nov 202544 days0001193125-25-280104
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107276
10-Q31 Mar 202514 May 202544 days0000950170-25-071349
10-K31 Dec 202420 Mar 202579 days0000950170-25-042623
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123245
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093858
10-Q31 Mar 20249 May 202439 days0000950170-24-056846
10-K31 Dec 202320 Mar 202480 days0000950170-24-034146
10-Q30 Sep 20237 Nov 202338 days0000950170-23-060200
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041272
10-Q31 Mar 202311 May 202341 days0000950170-23-021188
10-K31 Dec 202223 Mar 202382 days0000950170-23-009472
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024444
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016853
10-Q31 Mar 202212 May 202242 days0000950170-22-009649
10-K31 Dec 202114 Mar 202273 days0000950170-22-003577
10-Q30 Sep 202110 Nov 202141 days0000950170-21-004072
10-Q30 Jun 20219 Aug 202140 days0001564590-21-042607
10-Q31 Mar 20216 May 202136 days0001564590-21-024936
10-K31 Dec 202025 Mar 202184 days0001564590-21-015474

Source: SEC EDGAR company submissions for CIK 0001817229. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.